These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2935242

  • 1. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
    Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ.
    Cancer; 1986 Feb 01; 57(3):465-70. PubMed ID: 2935242
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P, Lewis BJ.
    J Clin Oncol; 1989 Nov 01; 7(11):1646-54. PubMed ID: 2530317
    [Abstract] [Full Text] [Related]

  • 3. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F, Bittner R, Roscher R, Schuhmacher K, Gaus W, Beger GH.
    Cancer; 1989 Jul 15; 64(2):379-87. PubMed ID: 2525415
    [Abstract] [Full Text] [Related]

  • 4. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G.
    Hepatogastroenterology; 2001 Jul 15; 48(41):1302-7. PubMed ID: 11677951
    [Abstract] [Full Text] [Related]

  • 5. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases.
    Barone RM, Byfield JE, Goldfarb PB, Frankel S, Ginn C, Greer S.
    Cancer; 1982 Sep 01; 50(5):850-62. PubMed ID: 6212114
    [Abstract] [Full Text] [Related]

  • 6. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ.
    Cancer; 1994 Feb 15; 73(4):1134-42. PubMed ID: 8313315
    [Abstract] [Full Text] [Related]

  • 7. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump.
    Weiss GR, Garnick MB, Osteen RT, Steele GD, Wilson RE, Schade D, Kaplan WD, Boxt LM, Kandarpa K, Mayer RJ.
    J Clin Oncol; 1983 May 15; 1(5):337-44. PubMed ID: 6199474
    [Abstract] [Full Text] [Related]

  • 8. Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2'-deoxyuridine.
    Hohn DC, Stagg RJ, Price DC, Lewis BJ.
    J Clin Oncol; 1985 Sep 15; 3(9):1257-60. PubMed ID: 3162003
    [Abstract] [Full Text] [Related]

  • 9. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P.
    J Surg Oncol; 2005 Aug 01; 91(2):97-101. PubMed ID: 16028279
    [Abstract] [Full Text] [Related]

  • 10. Fibrosis of extrahepatic biliary system after continuous hepatic artery infusion of floxuridine through an implantable pump (Infusaid pump).
    Haq MM, Valdes LG, Peterson DF, Gourley WK.
    Cancer; 1986 Apr 01; 57(7):1281-3. PubMed ID: 2936442
    [Abstract] [Full Text] [Related]

  • 11. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
    Lorenz M, Hottenrott C, Inglis R, Kirkowa-Reimann M.
    Gan To Kagaku Ryoho; 1989 Dec 01; 16(12):3662-71. PubMed ID: 2531992
    [Abstract] [Full Text] [Related]

  • 12. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.
    Kemeny MM, Battifora H, Blayney DW, Cecchi G, Goldberg DA, Leong LA, Margolin KA, Terz JJ.
    Ann Surg; 1985 Aug 01; 202(2):176-81. PubMed ID: 3160313
    [Abstract] [Full Text] [Related]

  • 13. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
    Patt YZ, Mavligit GM, Chuang VP, Wallace S, Johnston S, Benjamin RS, Valdivieso M, Hersh EM.
    Cancer; 1980 Jul 15; 46(2):261-5. PubMed ID: 6446376
    [Abstract] [Full Text] [Related]

  • 14. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
    Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Roullet Audy JC, Gallot D.
    J Clin Oncol; 1992 Jul 15; 10(7):1112-8. PubMed ID: 1296590
    [Abstract] [Full Text] [Related]

  • 15. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ, Boddie AW, Charnsangavej C, Ajani JA, Wallace S, Soski M, Claghorn L, Mavligit GM.
    J Clin Oncol; 1986 Sep 15; 4(9):1356-64. PubMed ID: 2943876
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.
    Stagg RJ, Venook AP, Chase JL, Lewis BJ, Warren RS, Roh M, Mulvihill SJ, Grobman BJ, Rayner AA, Hohn DC.
    J Natl Cancer Inst; 1991 Mar 20; 83(6):423-8. PubMed ID: 1825674
    [Abstract] [Full Text] [Related]

  • 18. Liver pathology following hepatic arterial infusion chemotherapy. Hepatic toxicity with FUDR.
    Doria MI, Shepard KV, Levin B, Riddell RH.
    Cancer; 1986 Aug 15; 58(4):855-61. PubMed ID: 2941140
    [Abstract] [Full Text] [Related]

  • 19. Neurologic toxicity associated with hepatic artery infusion HAI of FUdR.
    Taylor HG, Wolf CR, Maitland CG.
    Cancer Chemother Pharmacol; 1986 Aug 15; 17(3):292-3. PubMed ID: 2943526
    [Abstract] [Full Text] [Related]

  • 20. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M, Müller HH.
    J Clin Oncol; 2000 Jan 15; 18(2):243-54. PubMed ID: 10637236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.